Immediate Impact
67 standout
Citing Papers
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
2025 Standout
MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
2025 Standout
Works of Eshan Senanayake being referenced
Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Eshan Senanayake | 122 | 146 | 87 | 28 | 366 | |
| Donald C. Finlayson | 108 | 142 | 86 | 30 | 348 | |
| Marco Pavesi | 87 | 197 | 96 | 32 | 410 | |
| Andrew D. Jung | 74 | 224 | 73 | 32 | 366 | |
| Mustafa Şırlak | 112 | 164 | 89 | 34 | 386 | |
| Konstantinos Stamoulis | 104 | 109 | 80 | 31 | 360 | |
| Alireza Yaghoubi | 155 | 66 | 63 | 29 | 383 | |
| Suzanne Kats | 202 | 162 | 52 | 33 | 389 | |
| Alexander Nagrebetsky | 114 | 134 | 40 | 22 | 393 | |
| Srikanth Sridhar | 55 | 93 | 93 | 27 | 374 | |
| Ömer Faruk Doğan | 156 | 195 | 97 | 52 | 377 |
All Works
Login with ORCID to disown or claim papers
Loading papers...